Bullboard Post History

by DominicT

Order by:

TWIN	Kevin Harrington Discusses FSD Pharma {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 13, 2023
META	Kevin Harrington Discusses FSD Pharma {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 13, 2023
T.WEED	Kevin Harrington Discusses FSD Pharma {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 13, 2023
META	FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On... July 13, 2022
T.WEED	FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On... July 13, 2022
T.WEED	FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... June 3, 2022
META	FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... June 3, 2022
META	FSD Pharma Files Investigational New Drug Application “IND” FSD Pharma Files Investigational New Drug Application (“IND”) with... June 1, 2022
T.WEED	FSD Pharma Files Investigational New Drug Application “IND” FSD Pharma Files Investigational New Drug Application (“IND”) with... June 1, 2022
T.WEED	FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets ... May 10, 2022
META	FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets ... May 10, 2022
T.WEED	Lucid-MS for Multiple Sclerosis Treatment {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... May 1, 2022
META	Lucid-MS for Multiple Sclerosis Treatment {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 30, 2022
T.WEED	"Julia Levy Award" Recipient David Allan and Dr. John McGraw FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John... April 23, 2022